Hemab Therapeutics (COAG) Stock Chart
NASDAQ: COAGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
COAG technical summary
COAG is trading 33.8% below its 50-day simple moving average of $43.35. The 14-day Relative Strength Index (RSI) is 21.0, below 30, the level many traders consider oversold. Over the past year, the stock ranged from $23.00 (May 11, 2026) to $55.42 (Aug 14, 2026); the current price sits 18% of the way from the low to the high.
Annualized 30-day volatility is 56.8%. Based on the last session's high, low and close, the classic pivot point is $28.35, with first resistance at $29.33 and first support at $27.73. These indicators describe past price behavior for Hemab Therapeutics; they are not predictions.
Summary generated from market data by MetaCap's automated system. Methodology
Technical indicators
- RSI (14)
- 21.0
- 50-day SMA
- 43.35
- Beta
- —
- 1Y high
- 55.42 (Aug 14)
- 1Y low
- 23.00 (May 11)
- Last close
- 28.70
COAG price performance
1 week
-6.94%
1 month
-35.61%
3 months
-15.31%
COAG price return, excluding dividends.
Moving averages
| Period | Simple (SMA) | Exponential (EMA) |
|---|---|---|
| 5-day | 29.97Price below | 29.90Price below |
| 10-day | 31.68Price below | 31.81Price below |
| 20-day | 35.65Price below | 35.11Price below |
| 50-day | 43.35Price below | 38.90Price below |
| 100-day | 38.22Price below | 36.62Price below |
Moving averages are computed from daily closing prices over the past year. What is a moving average?
Pivot points
| Level | Price |
|---|---|
| Resistance 3 (R3) | 30.93 |
| Resistance 2 (R2) | 29.95 |
| Resistance 1 (R1) | 29.33 |
| Pivot point | 28.35 |
| Support 1 (S1) | 27.73 |
| Support 2 (S2) | 26.75 |
| Support 3 (S3) | 26.13 |
Classic floor-trader pivots from the last session's high, low and close. How pivot points work